查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年控制釋放給藥市場預測：按類型、釋放機制、應用和地區進行的全球分析
市場調查報告書
商品編碼
1383415

2030 年控制釋放給藥市場預測：按類型、釋放機制、應用和地區進行的全球分析

Controlled Release Drug Delivery Market Forecasts to 2030 - Global Analysis By Type, By Release Mechanism, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的數據，2023年全球控制釋放給藥市場規模為556.9億美元，預計到2030年將達到1,278億美元，預測期內年複合成長率為12.6%。

控制釋放藥物遞送是一種製藥技術，其重點是在較長時間內以即時和受控的方式將藥物給藥體內，這與在給藥後迅速釋放整個劑量的立即釋放製劑相反。控制釋放藥物輸送系統旨在實現特定的治療目標，例如維持血液中恆定的藥物濃度、最大限度地減少副作用、提高患者用藥醫囑遵從性以及提高整體治療效果。僅此而已。

根據《國家健康科學》公佈的統計數據，2021年英國將有約117萬人被診斷出患有慢性阻塞性肺病（COPD），佔總人口的1.9%。

慢性病增加

由於慢性病盛行率上升，控制釋放給藥市場不斷成長。隨著糖尿病、心血管疾病和神經系統疾病等疾病變得越來越普遍，對持續和標靶給藥系統的需求不斷增加。這些技術具有提高患者依從性、減少給藥頻率和最大限度減少副作用等優點。透過確保藥物的穩定和受控釋放，這些輸送系統在有效管理慢性疾病方面發揮關鍵作用。隨著全球慢性病負擔持續增加，對先進控制釋放給藥解決方案的需求預計將大幅成長。

比傳統方法成本更高

開發和製造控制釋放系統需要複雜的技術、專用材料和廣泛的研究，這增加了製造成本。結果，付款人、醫療保健系統和患者都承受著成本增加的負擔。控制釋放系統具有提高患者依從性和減少副作用的優點，但其高昂的成本使一些患者無法使用它們，這可能會阻礙市場擴張。

老年人和兒童人口增加

隨著人口老化的增加，治療慢性疾病的長期藥物管理的需求也隨之增加。同樣，在小兒科，控制釋放系統透過最大限度地減少精確給藥和頻繁給藥的需要來確保安全性和合規性。為了減少副作用並改善治療結果，這些病患小組經常需要個體化和一致的藥物傳遞。因此，隨著對滿足年輕人和老年人特定治療需求的控制釋放藥物輸送解決方案的需求不斷增加，市場正在擴大。

嚴格的法規核准

嚴格的法規核准對控制釋放給藥市場構成重大威脅。開發和商業化這些尖端的藥物輸送系統需要嚴格的測試並遵守複雜的法規要求，這既耗時又昂貴。獲得核准的這種延遲可能會阻礙市場成長和創新，抑制投資，並限制患者獲得改進的治療方法。

COVID-19 的影響：

COVID-19大流行控制釋放藥物輸送市場產生了重大影響。大流行期間對藥品和抗病毒治療藥物的需求激增，刺激了控制釋放藥物傳遞系統的開發和採用。然而，挑戰包括全球供應鏈中斷、臨床試驗減少以及醫療資源重新分配。此外，在此期間，對研究和開發的關注以及對遠端患者監護以對抗病毒的需求加速了控制釋放技術的創新和採用。

預計目標交付部分在預測期內將是最大的

在控制釋放給藥市場中，標靶給藥領域預計將佔據最大的市場佔有率。其背景是對個人化醫療的日益重視以及對準確靶向體內特定區域和細胞的藥物輸送系統的需求不斷成長。藥物傳輸具有減少副作用、增強藥物療效及改善患者治療效果等優點。這對於治療癌症等疾病尤其重要，因為局部和受控的藥物釋放非常有效。這些因素極大地推動了該細分市場的成長。

在預測期內，口服給藥系統領域預期複合年複合成長率最高

在控制釋放給藥市場中，口服控制釋放給藥系統領域預計將呈現最高的成長率。口服給藥因其方便、非侵入性而受到患者的青睞，需求量不斷增加。此外，製藥技術的不斷改進使得更有效的控制釋放系統成為可能。由於其能夠提高患者依從性、減少給藥頻率並提供長期穩定的藥物釋放，該市場可能會顯著成長。

佔比最大的地區：

預計在預測期內，北美將保持其在控制釋放給藥市場的主導地位。該地區發達的製藥業、發達的醫療基礎設施以及慢性病的高盛行率正在推動對先進給藥技術的需求。此外，研發方面的大量投資和強力的法律規範正在支持控制釋放藥物的創新和核准。該地區龐大的患者群體和主要市場參與企業的存在也有助於其在未來年度的優勢。

複合年複合成長率最高的地區：

由於人口成長、醫療保健基礎設施的發展以及中階的成長和醫療保健機會的改善，對先進藥物輸送系統的需求不斷增加，預計亞太地區的控制釋放藥物輸送市場將在預測期內成長。最高的成長。在亞太地區，糖尿病和癌症等慢性病的流行正在推動控制釋放藥物的採用，以實現更好的管理。此外，增加研發投資也有助於該地區強勁的成長潛力，使其成為全球市場的強大參與者。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球控制釋放給藥市場：依技術分類

  • 阿爾斯特技術
  • 凝聚
  • 植入
  • 脂質體
  • 微膠囊化
  • 電子機械技術
  • 定向投放
  • 經皮的
  • 其他技術

第6章 全球控制釋放給藥市場：依釋放機制分類

  • 基於聚合物的系統
  • 回饋法規給藥系統
  • 微儲庫分區控制給藥系統
  • 活化調節的藥物遞送系統
    • 動態壓力驅動
    • 磁力驅動
    • 機械操作的
    • 滲透激活
    • 蒸氣壓活化
  • 化學活化
    • 酶激活
    • 水解活化
    • pH值活化
  • 其他釋放機制

第7章 全球控制釋放給藥市場：依應用分類

  • 定量吸入器
  • 藥物釋放型支架
  • 點滴幫浦
  • 可注射的
  • 口服控釋給藥系統
  • 經皮吸收貼片和眼科貼劑
  • 其他用途

第8章 全球控制釋放給藥市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Abbott Laboratories
  • Alkermes plc
  • Aradigm Corporation
  • Bayer HealthCare LLC
  • Bracco SpA
  • Bristol-Myers Squibb
  • Capsugel
  • Coating Place, Inc.
  • Corium International, Inc.
  • Depomed, Inc.
  • GE Healthcare
  • GSK plc
  • Guerbet Group
  • Johnson and Johnson Ltd.
  • Medtronic AG
  • Merck and Co.Inc.
  • Mylan NV
  • Orbis Biosciences.Inc.
  • Pfizer, Inc.
  • Roche Holding AG
  • Sanofi
  • Sino Medical-Device Technology Co.
  • Sun Pharmaceuticals Industries Ltd
  • Ulrich GmbH & Co. KG
  • Vectura Group plc
Product Code: SMRC24264

According to Stratistics MRC, the Global Controlled Release Drug Delivery Market is accounted for $55.69 billion in 2023 and is expected to reach $127.80 billion by 2030 growing at a CAGR of 12.6% during the forecast period. Controlled release drug delivery is a pharmaceutical technology focused on administering medications to the body in a gradual and regulated manner over an extended period, in contrast to immediate-release formulations that deliver the entire dose rapidly upon administration. The goal of controlled-release drug delivery systems is to achieve specific therapeutic objectives, such as maintaining consistent drug levels in the bloodstream, minimizing adverse effects, enhancing patient adherence, and improving the overall effectiveness of treatment.

According to statistics published by National Health Science, about 1.17 million people in England were diagnosed with chronic obstructive pulmonary disorder (COPD) in 2021, accounting for 1.9% of the total population.

Market Dynamics:

Driver:

Rising incidence of chronic diseases

The controlled release drug delivery market is seeing growth propelled by the escalating prevalence of chronic diseases. With conditions like diabetes, cardiovascular disorders, and neurological ailments becoming more prevalent, there is an increased demand for sustained and targeted drug delivery systems. These technologies offer benefits such as improved patient compliance, reduced dosing frequency, and minimized side effects. By ensuring a steady and controlled release of medications, these delivery systems play a crucial role in managing chronic conditions effectively. As the global burden of chronic diseases continues to rise, the demand for advanced controlled-release drug delivery solutions is expected to expand significantly.

Restraint:

Higher cost compared to the conventional method

Production costs are increased by the need for complex technologies, specialty materials, and extensive research when developing and manufacturing controlled release systems. As a result, payers, healthcare systems, and patients all bear the increased costs. Although there are benefits associated with controlled release systems, such as better patient compliance and fewer side effects, their higher cost may prevent some patients from using them and thus impede market expansion.

Opportunity:

Growing geriatric and pediatric population

The need for extended medication management to treat chronic health conditions is growing as the elderly population grows. In Similar to this, controlled release systems in pediatrics ensure safety and compliance by offering precise dosing and minimizing the need for frequent administration. To reduce side effects and improve treatment outcomes, these patient groups frequently need individualized, consistent medication delivery. As a result, the market is expanding due to the growing demand for controlled release drug delivery solutions that meet the specific therapeutic needs of both younger and older populations.

Threat:

Stringent regulatory approvals

Stringent regulatory approvals pose a significant threat to the controlled release drug delivery market. Developing and marketing these advanced drug delivery systems requires rigorous testing and compliance with complex regulatory requirements, which can be time-consuming and costly. Such delays in obtaining approvals can hinder the market's growth and innovation, deterring investment and potentially limiting patient access to improved therapies.

COVID-19 Impact:

The COVID-19 pandemic significantly influenced the controlled release drug delivery market. The increased demand for pharmaceuticals and antiviral treatments surged during the pandemic, driving the development and adoption of controlled-release drug delivery systems. However, disruptions in the global supply chain, reduced clinical trials, and healthcare resource reallocation posed challenges. Additionally, the focus on research and development to combat the virus and the need for remote patient monitoring accelerated the innovation and adoption of controlled release technologies during this period.

The targeted delivery segment is expected to be the largest during the forecast period

The targeted delivery segment is anticipated to capture the largest market share in the controlled drug delivery market. This prominence is attributed to the growing emphasis on personalized medicine and the need for drug delivery systems that can precisely target specific sites or cells in the body. Targeted delivery offers the advantages of reduced side effects, enhanced drug efficacy, and improved patient outcomes. It is particularly crucial in the treatment of conditions like cancer, where localized and controlled drug release can be highly effective. These factors significantly drive the segment's growth.

The oral controlled-drug delivery systems segment is expected to have the highest CAGR during the forecast period

In the controlled release drug delivery market, the oral controlled-drug delivery systems segment is anticipated to grow at the highest rate. Patients prefer the oral route of drug administration because it is convenient and non-invasive, which has increased demand for it. Moreover, more efficient oral controlled-release systems have been made possible by continuous improvements in pharmaceutical technology. The market is well-positioned for substantial growth due to its ability to improve patient compliance, lower the frequency of doses, and deliver a consistent release of medications over time.

Region with largest share:

North America is projected to sustain its leading position in the controlled release drug delivery market during the forecast period. The region has a well-established pharmaceutical industry, a robust healthcare infrastructure, and a high prevalence of chronic diseases, driving the demand for advanced drug delivery technologies. Additionally, substantial investments in research and development, coupled with strong regulatory frameworks, encourage innovation and the approval of controlled-release drug products. The region's large patient population, along with the presence of key market players, contributes to its dominance in the coming years.

Region with highest CAGR:

The Asia Pacific region is estimated to witness the highest growth in the controlled release drug delivery market during the forecast period owing to the region's rising population, increasing healthcare infrastructure, and a growing middle class with greater access to healthcare, which are driving demand for advanced drug delivery systems. The prevalence of chronic diseases in Asia Pacific, such as diabetes and cancer, is boosting the adoption of controlled-release drugs for better management. Additionally, the increasing investments in research and development contribute to the region's significant growth potential, making it a prominent player in the global market.

Key players in the market

Some of the key players in Controlled Release Drug Delivery market include: Abbott Laboratories, Alkermes plc, Aradigm Corporation, Bayer HealthCare LLC, Bracco S.p.A., Bristol-Myers Squibb, Capsugel, Coating Place, Inc., Corium International, Inc., Depomed, Inc., GE Healthcare, GSK plc, Guerbet Group, Johnson and Johnson Ltd., Medtronic AG, Merck and Co.Inc., Mylan N.V., Orbis Biosciences.Inc., Pfizer, Inc., Roche Holding AG, Sanofi, Sino Medical-Device Technology Co., Sun Pharmaceuticals Industries Ltd, Ulrich GmbH & Co. KG and Vectura Group plc.

Key Developments:

In April 2023, Researchers at the Indian Institute of Technology Guwahati (IIT-G) have developed liquid marbles using nano clay that can be pre-programmed for drug delivery and cascade chemical reactions. The IIT-G team has used the liquid marbles approach for the controlled release of drugs and programmed chemical reaction. The team has engineered liquid marbles to have a 'time bomb' type release effect and to carry out a spontaneous chemical reaction. The nano clay marbles were made of a shell of nanoclay that holds the liquid. To programme the marbles for timed release of the content, the researchers modified the nanoclay with chemical groups that were either water-loving (hydrophilic) or waterhating (hydrophobic).

In December 2022, InSitu Biologics, Inc. is pleased to announce that it has entered into an agreement with the Mayo Foundation for Medical Education and Research to further develop its prolonged-release drug delivery technology for anti-cancer therapeutics.

Technologies Covered:

  • Wurster Technique
  • Coacervation
  • Implants
  • Liposomes
  • Micro Encapsulation
  • Microelectromechanical Technology
  • Targeted Delivery
  • Transdermal
  • Other Technologies

Release Mechanisms Covered:

  • Polymer Based Systems
  • Feedback Regulated Drug Delivery Systems
  • Micro Reservoir Partition Controlled Drug Delivery Systems
  • Activation-modulated Drug Delivery Systems
  • Chemically Activated
  • Other Release Mechanisms

Applications Covered:

  • Metered Dose Inhalers
  • Drug Eluting Stents
  • Infusion Pumps
  • Injectable
  • Oral Controlled-drug delivery Systems
  • Transdermal and Ocular Patches
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Controlled Release Drug Delivery Market, By Technology

  • 5.1 Introduction
  • 5.2 Wurster Technique
  • 5.3 Coacervation
  • 5.4 Implants
  • 5.5 Liposomes
  • 5.6 Micro Encapsulation
  • 5.7 Microelectromechanical Technology
  • 5.8 Targeted Delivery
  • 5.9 Transdermal
  • 5.10 Other Technologies

6 Global Controlled Release Drug Delivery Market, By Release Mechanism

  • 6.1 Introduction
  • 6.2 Polymer Based Systems
  • 6.3 Feedback Regulated Drug Delivery Systems
  • 6.4 Micro Reservoir Partition Controlled Drug Delivery Systems
  • 6.5 Activation-modulated Drug Delivery Systems
    • 6.5.1 Hydrodynamic Pressure Activated
    • 6.5.2 Magnetically Activated
    • 6.5.3 Mechanically Activated
    • 6.5.4 Osmotic Pressure Activated
    • 6.5.5 Vapor Pressure Activated
  • 6.6 Chemically Activated
    • 6.6.1 Enzyme Activated
    • 6.6.2 Hydrolysis Activated
    • 6.6.3 pH Activated
  • 6.7 Other Release Mechanisms

7 Global Controlled Release Drug Delivery Market, By Application

  • 7.1 Introduction
  • 7.2 Metered Dose Inhalers
  • 7.3 Drug Eluting Stents
  • 7.4 Infusion Pumps
  • 7.5 Injectable
  • 7.6 Oral Controlled-drug delivery Systems
  • 7.7 Transdermal and Ocular Patches
  • 7.8 Other Applications

8 Global Controlled Release Drug Delivery Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 Alkermes plc
  • 10.3 Aradigm Corporation
  • 10.4 Bayer HealthCare LLC
  • 10.5 Bracco S.p.A.
  • 10.6 Bristol-Myers Squibb
  • 10.7 Capsugel
  • 10.8 Coating Place, Inc.
  • 10.9 Corium International, Inc.
  • 10.10 Depomed, Inc.
  • 10.11 GE Healthcare
  • 10.12 GSK plc
  • 10.13 Guerbet Group
  • 10.14 Johnson and Johnson Ltd.
  • 10.15 Medtronic AG
  • 10.16 Merck and Co.Inc.
  • 10.17 Mylan N.V.
  • 10.18 Orbis Biosciences.Inc.
  • 10.19 Pfizer, Inc.
  • 10.20 Roche Holding AG
  • 10.21 Sanofi
  • 10.22 Sino Medical-Device Technology Co.
  • 10.23 Sun Pharmaceuticals Industries Ltd
  • 10.24 Ulrich GmbH & Co. KG
  • 10.25 Vectura Group plc

List of Tables

  • Table 1 Global Controlled Release Drug Delivery Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Controlled Release Drug Delivery Market Outlook, By Technology (2021-2030) ($MN)
  • Table 3 Global Controlled Release Drug Delivery Market Outlook, By Wurster Technique (2021-2030) ($MN)
  • Table 4 Global Controlled Release Drug Delivery Market Outlook, By Coacervation (2021-2030) ($MN)
  • Table 5 Global Controlled Release Drug Delivery Market Outlook, By Implants (2021-2030) ($MN)
  • Table 6 Global Controlled Release Drug Delivery Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 7 Global Controlled Release Drug Delivery Market Outlook, By Micro Encapsulation (2021-2030) ($MN)
  • Table 8 Global Controlled Release Drug Delivery Market Outlook, By Microelectromechanical Technology (2021-2030) ($MN)
  • Table 9 Global Controlled Release Drug Delivery Market Outlook, By Targeted Delivery (2021-2030) ($MN)
  • Table 10 Global Controlled Release Drug Delivery Market Outlook, By Transdermal (2021-2030) ($MN)
  • Table 11 Global Controlled Release Drug Delivery Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 12 Global Controlled Release Drug Delivery Market Outlook, By Release Mechanism (2021-2030) ($MN)
  • Table 13 Global Controlled Release Drug Delivery Market Outlook, By Polymer Based Systems (2021-2030) ($MN)
  • Table 14 Global Controlled Release Drug Delivery Market Outlook, By Feedback Regulated Drug Delivery Systems (2021-2030) ($MN)
  • Table 15 Global Controlled Release Drug Delivery Market Outlook, By Micro Reservoir Partition Controlled Drug Delivery Systems (2021-2030) ($MN)
  • Table 16 Global Controlled Release Drug Delivery Market Outlook, By Activation-modulated Drug Delivery Systems (2021-2030) ($MN)
  • Table 17 Global Controlled Release Drug Delivery Market Outlook, By Hydrodynamic Pressure Activated (2021-2030) ($MN)
  • Table 18 Global Controlled Release Drug Delivery Market Outlook, By Magnetically Activated (2021-2030) ($MN)
  • Table 19 Global Controlled Release Drug Delivery Market Outlook, By Mechanically Activated (2021-2030) ($MN)
  • Table 20 Global Controlled Release Drug Delivery Market Outlook, By Osmotic Pressure Activated (2021-2030) ($MN)
  • Table 21 Global Controlled Release Drug Delivery Market Outlook, By Vapor Pressure Activated (2021-2030) ($MN)
  • Table 22 Global Controlled Release Drug Delivery Market Outlook, By Chemically Activated (2021-2030) ($MN)
  • Table 23 Global Controlled Release Drug Delivery Market Outlook, By Enzyme Activated (2021-2030) ($MN)
  • Table 24 Global Controlled Release Drug Delivery Market Outlook, By Hydrolysis Activated (2021-2030) ($MN)
  • Table 25 Global Controlled Release Drug Delivery Market Outlook, By pH Activated (2021-2030) ($MN)
  • Table 26 Global Controlled Release Drug Delivery Market Outlook, By Other Release Mechanisms (2021-2030) ($MN)
  • Table 27 Global Controlled Release Drug Delivery Market Outlook, By Application (2021-2030) ($MN)
  • Table 28 Global Controlled Release Drug Delivery Market Outlook, By Metered Dose Inhalers (2021-2030) ($MN)
  • Table 29 Global Controlled Release Drug Delivery Market Outlook, By Drug Eluting Stents (2021-2030) ($MN)
  • Table 30 Global Controlled Release Drug Delivery Market Outlook, By Infusion Pumps (2021-2030) ($MN)
  • Table 31 Global Controlled Release Drug Delivery Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 32 Global Controlled Release Drug Delivery Market Outlook, By Oral Controlled-drug delivery Systems (2021-2030) ($MN)
  • Table 33 Global Controlled Release Drug Delivery Market Outlook, By Transdermal and Ocular Patches (2021-2030) ($MN)
  • Table 34 Global Controlled Release Drug Delivery Market Outlook, By Other Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.